Denmark· DK-28106443120
Abecma
A idecabtagene vicleucel product, registered in Denmark by Bristol-Myers Squibb Pharma EEIG. The same ATC class is registered in 10 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Idecabtagene vicleucel is registered in 10 of 19 countries.
Countries holding a registration under ATC L01XL07 (idecabtagene vicleucel), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Idecabtagene vicleucel · ATC L01XL07
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Manufacturer
- Bristol-Myers Squibb Pharma EEIG
- Country
- Denmark (DK)
- ATC code
- L01XL07
- ATC class
- Idecabtagene vicleucel
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106443120
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L01XL07
Idecabtagene vicleucel, as other registers publish it.
- United StatesAbecmaCelgene Corporation
- FinlandAbecmaBristol-Myers Squibb Pharma EEIG
- PolandAbecmaBristol-Myers Squibb Pharma EEIG
- IcelandAbecmaBristol-Myers Squibb Pharma EEIG*
- United StatesAbecmaCelgene Corporation
- CzechiaABECMABristol-Myers Squibb Pharma EEIG, Dublin
- FranceABECMA 260 - 500 x 1 000 000 cellules, dispersion pour perfusionBRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
- BelgiumAbecma 260-500 x 10*6 cellsBristol-Myers Squibb Pharma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4b6837e-09ef-4e6b-8f13-e8d6a9367411 GET /v1/drugs/f4b6837e-09ef-4e6b-8f13-e8d6a9367411?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "infusionsvæske, dispersion",
"source": "dkma",
"strength": "86",
"auth_role": "MOD",
"dk_drugid": "28106443120",
"substance": null,
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "44427"
}See everything about idecabtagene vicleucel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.